Platelet glutamate dehydrogenase activity and efficacy of antipsychotic therapy in patients with schizophrenia

Por Savushkina Olga K., Tereshkina Elena B., Prokhorova Tatiana A., Boksha Irina S., Burminskii Denis S., Vorobyeva Elena A., Morozova Margarita A., Burbaeva Gulnur Sh.
Publicado em 2020-01-01

SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects

Por Haddad, Peter M, Fleischhacker, W Wolfgang, Peuskens, Joseph, Cavallaro, Roberto, Lean, Michael EJ, Morozova, Margarita, Reynolds, Gavin, Azorin, Jean-Michel, Thomas, Pierre, Möller, Hans-Jürgen
Publicado em 2014

A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia

Por Downing, AnnCatherine M, Kinon, Bruce J, Millen, Brian A, Zhang, Lu, Liu, Lin, Morozova, Margarita A, Brenner, Ronald, Rayle, Tami Jo, Nisenbaum, Laura, Zhao, Fangyi, Gomez, Juan Carlos
Publicado no BMC Psychiatry (2014)